TABLE 4.

Nonadherence Based on Medication Monitoring, by Medication Class

Medication Type	Adherence <90%
Overall nonadherence in entire cohort (n = 112)	17.9% (n = 20)
Oral medication (n = 102)	17.6% (n = 18)
Infusion biologic (n = 41)	2.4% (n = 1)
Adalimumab s.c. (n = 24)	4.2% (n = 1)
	Adherence <80%
Overall nonadherence in entire cohort (n = 112)	9.8% (n = 11)
Oral medication (n = 102)	10.7% (n = 11)
Infusion biologic (n = 41)	0% (n = 0)
Adalimumab s.c. (n = 24)	0% (n = 0)

Nonadherence calculated as percentage of medications taken relative to medications prescribed.

s.c., subcutaneous.